Lupin acquires Gavis and Novel for $880mm
Executive Summary
In its first major US acquisition, Lupin Ltd. paid $880mm for private companies Gavis Pharmaceuticals LLC and Novel Laboratories Inc.
Deal Industry
- Distributors
- Pharmaceuticals
- Services
-
Pharmaceuticals
- Generic Drugs
-
Drug Delivery
- Controlled Release
- Pulmonary
- Topical Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice